Inspection Record

Bio Nuclear Diagnostics Inc. — Health Canada Inspection Findings

Health CanadaInspected 2025-05-12 3 findingsStability and storageOther quality systemQuality unit oversight

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

2Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

3Quality unit oversight

The annual product quality review procedure was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-05-12. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Bio Nuclear Diagnostics Inc. company profile — full history Health Canada documents, 2025 Go to Findings search